Cardiology (all articles)
Randomized Trial: Effects of n−3 Fatty Acid Supplements in Diabetes Mellitus
31 Aug, 2018 | 02:58h | UTCEffects of n−3 Fatty Acid Supplements in Diabetes Mellitus – New England Journal of Medicine (free for a limited period)
Commentaries: Fish oils do not prevent heart attack or strokes in people with diabetes – ESC News Releases (free) AND Omega-3 Fatty Acids Fail to Reduce CVD Events in Diabetic Patients: ASCEND – TCTMD (free)
Related Cochrane Review: Omega-3 fatty Acids for the Prevention of Cardiovascular Disease (link to abstract and commentaries)
Related Meta-Analysis: Omega-3 Fatty Acid Supplements Don’t Reduce Cardiovascular Risk (free study and commentary)
CHEST Guideline: Antithrombotic Therapy for Atrial Fibrillation
31 Aug, 2018 | 02:56h | UTCAntithrombotic Therapy for Atrial Fibrillation: CHEST Guideline and Expert Panel Report (free PDF)
News Release: The American College of Chest Physicians updates their antithrombotic therapy guidelines for patients with atrial fibrillation (free)
Randomized Trial: High-Sensitivity Troponin in the Evaluation of Suspected Acute Coronary Syndrome
31 Aug, 2018 | 02:49h | UTCCommentaries: Diagnosing myocardial infarction: a highly sensitive issue – The Lancet (free) AND Hs-TnI in Suspected ACS: High-STEACS Trial – American College of Cardiology (free) AND Is High Sensitivity Troponin Too Sensitive? – NEJM Journal Watch (free)
“Introduction of a high-sensitivity cardiac troponin I assay reclassified 1 in 6 patients with previously undetected myocardial necrosis, but did not lead to improved clinical outcomes in this large randomised trial” (via @chapdoc1 see Tweet)
“Very important study. What’s weird is that the “better” (more sensitive) troponin assays get, the less helpful the test becomes at the bedside. Look for a coming tsunami of iatrogenesis from overzealous evaluation of troponin bumps.” (via @drjohnm see Tweet)
Guideline: Management of Hypertensive Emergencies
31 Aug, 2018 | 02:45h | UTCESC Council on hypertension position document on the management of hypertensive emergencies – European Heart Journal – Cardiovascular Pharmacotherapy (free) (@Abraham_RMI)
“Patients that lack acute hypertension-mediated end organ damage to the heart, retina, brain, kidneys, or large arteries do not have a hypertensive emergency and can be treated with oral BP-lowering agents and usually discharged after a brief period of observation.”
Evidence Review: Optimal Blood Pressure Target in Diabetic and Nondiabetic Hypertensive Patients
31 Aug, 2018 | 02:44h | UTCSee counterpoint suggesting lower BP targets: Sprinting Toward the Optimal Blood Pressure Target for Hypertensive Patients – Circulation Research (free)
“We have reviewed the randomized trial evidence in favor of a target blood pressure (BP) around 130/80 mm Hg in hypertensive patients with and without diabetes mellitus”
Randomized Trial: Early vs. Standard Care Invasive Examination and Treatment of Patients with NSTE-ACS
31 Aug, 2018 | 02:29h | UTCEditorial: Timing of Intervention in Non ST Elevation Acute Coronary Syndromes: And the VERDICT is? (free PDF)
Commentaries: VERDICT: Very Early Invasive Coronary Angiography vs. Standard Care in NSTE-ACS Patients- American College of Cardiology (free) AND ESC: Early Invasive Strategy in NSTEMI Does Not Improve Outcomes – MedPage Today (free registration required) AND VERDICT: Very Early Invasive Angiography No Help Overall for NSTE ACS – TCTMD (free)
Randomized Trial: Radial vs. Femoral Access in Invasively Managed Patients with ACS
31 Aug, 2018 | 02:27h | UTCRadial versus femoral access and bivalirudin versus unfractionated heparin in invasively managed patients with acute coronary syndrome (MATRIX): final 1-year results of a multicentre, randomised controlled trial – The Lancet (link to abstract – $ for full-text)
Commentaries: MATRIX: 1-Year Results Confirm Superiority of Transradial PCI – TCTMD (free) AND Radial vs. Femoral Access for Angiography with or Without Bivalirudin in Patients with Acute Coronary Syndrome – NEJM Journal Watch (free for a limited period) AND ESC: Radial Access Tied to Better 1-Year Outcomes in ACS – MedPage Today (free registration required)
Study: Imaging of Coronary Inflammation for Cardiovascular Risk Prediction
31 Aug, 2018 | 02:28h | UTCCommentaries: Imaging of coronary inflammation for cardiovascular risk prediction – The Lancet (free) AND New Imaging Biomarker of Coronary Inflammation Shows Prognostic Value Exceeding All Current Noninvasive Measures – Cleveland Clinic (free) AND Imaging biomarker can predict coronary inflammation – UPI (free)
Study: Deep Forehead Wrinkles May Signal a Higher Risk for Cardiovascular Mortality
31 Aug, 2018 | 02:10h | UTCDeep forehead wrinkles may signal a higher risk for cardiovascular mortality – ESC Press Releases (free)
Commentaries: Forehead wrinkles – an early sign of cardiovascular disease? – Medical News Today (free) AND Excessive forehead wrinkles may be early sign of atherosclerosis – Cardiovascular Business (free)
Cohort Study: Psychological Distress and Risk of Myocardial Infarction and Stroke
31 Aug, 2018 | 02:10h | UTCCommentaries: Distress boosts heart attack and stroke risk – Medical News Today (free) AND High Mental Distress Tied to Heart Troubles – MedPage Today (free registration required)
Randomized Trial: One-Year Outcomes after PCI Strategies in Cardiogenic Shock
31 Aug, 2018 | 02:05h | UTCOne-Year Outcomes after PCI Strategies in Cardiogenic Shock – New England Journal of Medicine (free for a limited period)
Commentaries: Less Is Still More in Patients with Acute Myocardial Infarction and Cardiogenic Shock – NEJM Journal Watch (free for a limited period) AND 1-year outcomes still support culprit-only PCI for cardiogenic shock – Cardiovascular Business (free) CULPRIT-SHOCK: 1-Year Results Continue to Support Culprit-Only PCI for Shock Patients – TCTMD (free)
Randomized Trial: Telemedicine in Heart Failure Patients
31 Aug, 2018 | 02:04h | UTCEfficacy of telemedical interventional management in patients with heart failure (TIM-HF2): a randomised, controlled, parallel-group, unmasked trial – The Lancet (link to abstract – $ for full-text)
Commentaries: Telemedicine in Heart Failure Patients (TIM-HF2) – American College of Cardiology (free) AND ESC: Telemonitoring of HF Cuts Admissions, Mortality MedPage Today (free registration required)
Randomized Trial: Cardiovascular Safety of Lorcaserin in Overweight or Obese Patients
31 Aug, 2018 | 01:58h | UTCCardiovascular Safety of Lorcaserin in Overweight or Obese Patients – New England Journal of Medicine (free for a limited period)
Editorial: Lorcaserin — Elixir or Liability? (free for a limited period)
Commentaries: CAMELLIA-TIMI 61: Weight Loss Drug Lorcaserin Did Not Increase CV Events – American College of Cardiology (free) AND Weight-Loss Drug Lorcaserin Clears Cardiovascular Safety Hurdle: CAMELLIA-TIMI 61 – TCTMD (free) AND Weight loss drug lorcaserin found safe in large study – Reuters (free)
Cohort Study: No Survival Benefit with Beta-Blockers Beyond 1 Year Post-MI in Stable CAD
31 Aug, 2018 | 01:55h | UTCCLARIFY: No Survival Benefit With Beta-Blockers Beyond 1 Year Post-MI in Stable CAD – TCTMD (free)
Related Study: B-Blockers and Mortality After Acute Myocardial Infarction in Patients Without Heart Failure or Ventricular Dysfunction (free study and commentary)
“The problem, said Sorbets, is that there have never been large randomized trials to test the prognostic effects of beta-blockers in this patient group and instead, recommendations have been drawn from meta-analyses using data extracted from the acute MI setting or from observational studies.”
Randomized Trial: Tafamidis Treatment for Patients with Transthyretin Amyloid Cardiomyopathy
31 Aug, 2018 | 01:56h | UTCTafamidis Treatment for Patients with Transthyretin Amyloid Cardiomyopathy – New England Journal of Medicine (free for a limited period)
Editorial: Stabilizing Transthyretin to Treat ATTR Cardiomyopathy (free for a limited period)
Commentaries: Tafamidis, a Transthyretin Stabilizer, Offers Hope for Rare Cardiomyopathy – TCTMD (free) AND ATTR-ACT: Tafamidis Findings Offer Hope For Patients With ATTR-CM – American College of Cardiology (free) AND Drug reduces deaths and hospitalizations from underdiagnosed form of heart failure – Columbia University Irving Medical Center, via EurekAlert (free)
Study: Coronary CT Angiography and 5-Year Risk of Myocardial Infarction
31 Aug, 2018 | 01:55h | UTCCoronary CT Angiography and 5-Year Risk of Myocardial Infarction – New England Journal of Medicine (free for a limited period)
Commentary: Five Reasons I Don’t Believe an Imaging Test Improves Outcomes – by Dr. John Mandrola, in Medscape (free registration required)
See also an interesting Tweetorial by @AnilMakam, also suggesting caution before adopting this study results in clinical practice.
Study: Association of Cardiovascular Health Level in Older Age With Cognitive Decline and Incident Dementia
23 Aug, 2018 | 23:45h | UTCAssociation of Cardiovascular Health Level in Older Age With Cognitive Decline and Incident Dementia – JAMA (link to abstract – $ for full-text)
Commentaries: Study confirms that keeping the heart healthy also reduces dementia risk – NHS Choices (free) AND The Healthier Your Heart, the Healthier Your Brain May Be – The New York Times (10 articles per month are free) AND Cardiovascular Risk Factors Also Linked to Dementia – MedicalResearch.com (free)
Consensus: Management of Antithrombotic Therapy in AF Patients Presenting with ACS and/or Undergoing PCI
23 Aug, 2018 | 23:27h | UTCJoint Consensus Document: Management of antithrombotic therapy in AF patients presenting with ACS and/or undergoing PCI – European Heart Journal (free)
Position Statement: Management of Heart Failure in India
23 Aug, 2018 | 23:26h | UTCCSI position statement on management of heart failure in India – Indian Heart Journal (free)
Cohort Study: Long-Term Association of LDL Cholesterol With Cardiovascular Mortality in Low-Risk Individuals
23 Aug, 2018 | 23:22h | UTCCommentaries: ‘Bad’ cholesterol can be deadly in otherwise healthy people – AHA News (free) AND LDL >160 Tied to Increased Mortality in Low-Risk Patients – Physician’s First Watch (free) AND Study: Elevated LDL, non-HDL increase CVD mortality risk in young, healthy individuals – Cardiovascular Business (free) AND Moderate ‘bad cholesterol’ levels tied to early death for healthy people – Reuters (free)
AHA Guideline: Chagas Cardiomyopathy
23 Aug, 2018 | 23:20h | UTCAHA News Release: Chagas disease, caused by a parasite, has spread outside of Latin America and carries a high risk of heart disease (free)
Top Ten Things to Know: Chagas Cardiomyopathy: An Update of Current Clinical Knowledge and Management (free PDF)
Study: Clinical Chemistry Score to Identify Patients at Low or High Risk for Myocardial Infarction or Death
23 Aug, 2018 | 22:36h | UTCCommentaries: Simple score to diagnose heart attacks is safer, faster than current methods – McMaster University (free) AND Clinical Chemistry Score Helps Rule Out Diagnosis of Heart Attack – MedicalResearch.com (free)
Report: E-Cigarettes
23 Aug, 2018 | 22:33h | UTCReport: E-Cigarettes – House of Commons Science and Technology Committee (free PDF)
Commentaries: Stop treating e-cigs like conventional cigarettes, MPs tell NHS – OnMedica (free) AND E-cigarettes can be key weapon against smoking, say MPs – BBC (free)
See also: related guidelines, reports and commentaries on e-cigarettes (all free)
Study: Association Between Electronic Cigarette Use and Myocardial Infarction
23 Aug, 2018 | 22:35h | UTCAssociation Between Electronic Cigarette Use and Myocardial Infarction – American Journal of Preventive Medicine (free for a limited period)
Commentary: Risk of heart attacks is double for daily e-cigarette users – University of California – San Francisco, via ScienceDaily (free)
“New analysis shows five-fold risk for people who use both cigarettes and e-cigarettes daily” (from ScienceDaily)
Review: Airway and Ventilation Management During CPR and After Successful Resuscitation
23 Aug, 2018 | 22:27h | UTC


